<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02865239</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A00578-41</org_study_id>
    <nct_id>NCT02865239</nct_id>
  </id_info>
  <brief_title>Feasibility Study of Breast MRI in Decubitus Position</brief_title>
  <acronym>EFIMED</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Cancérologie de Lorraine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut de Cancérologie de Lorraine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Breast MRI is performed in prone position which causes a number of questions. Indeed, the
      correlation with mammography and echography and the identification of preoperative lesions
      can be complex as echography and surgery are carried in supine position while mammography is
      performed in standing position.

      Moreover, the prone position is often considered as uncomfortable by the patients. However,
      there is few publications in the literature on breast MRI in decubitus position.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of lesions where the topography is discordant between the positions (prone and supine).</measure>
    <time_frame>1 day</time_frame>
    <description>The topography is considered discordant if the location of the lesion is different between prone and supine positions (location will be described as the positions on a clock) and / or the distance from the nipple to the lesion is greater than 2cm between prone and supine positions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comfort patient in supine position compared to the prone position using a self-administered questionnaire</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>distance from the anterior border of the lesion to the nipple in supine position compared to the prone position</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>distance from cutaneous projection of the lesion to the nipple in supine position compared to the prone position</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>distance from lesion to pectoralis major muscle in supine position compared to the prone position</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quandrant of the lesions and positions on a clock in supine position compared to the prone position</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Supine position</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>3.0 tesla MRI in supine position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prone position</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3.0 tesla MRI in prone position</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Position for the 3.0 Tesla in Magnetic Resonance Imaging</intervention_name>
    <description>Eligible patients will have a standard MRI in prone position. At the end of this examination, all patients will have an other standard MRI in supine position.
This examination is then extended by 10 minutes without additional injection of contrast medium</description>
    <arm_group_label>Supine position</arm_group_label>
    <arm_group_label>Prone position</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient to benefit a MRI in the assessment for a breast carcinoma or a suspicious of
             breast carcinoma

          -  Assessment on 3.0 Tesla in Magnetic Resonance Imaging

          -  Age &gt;18 years old

          -  ECOG performance status ≤ 3

          -  Ability to provide written informed consent form

        Exclusion Criteria:

          -  Age &lt; 18 years old

          -  Claustrophobia

          -  Contraindication to the injection of contrast medium Gadoline

          -  Contraindication to MRI

          -  Persons deprived of liberty or under supervision
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>OLDRINI GUILLAUME, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut de Cancérologie de Lorraine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut de Cancérologie de Lorraine</name>
      <address>
        <city>Vandoeuvre-lès-Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2016</study_first_submitted>
  <study_first_submitted_qc>August 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2016</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Imaging, Three-Dimensional</keyword>
  <keyword>Magnetic Resonance Imaging/methods*</keyword>
  <keyword>Breast Neoplasms/diagnosis*</keyword>
  <keyword>Prone Position</keyword>
  <keyword>Prospective Studies</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

